April 9th, 2015
Selections from Richard Lehman’s Literature Review: April 9th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PROMISE trial, the efficacy of folic acid therapy in primary prevention of stroke among patients with hypertension in China, and more.
February 2nd, 2015
Selections from Richard Lehman’s Literature Review: February 2nd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include less-tight vs. tight hypertension control in pregnancy, icatibant for ACE-inhibitor-induced angioedema, and more.
June 24th, 2014
In Emerging China, STEMI Admissions Skyrocket But Treatment Lags
Larry Husten, PHD
Accompanying all the other changes in China over the past decade, admission to the hospital for ST-segment elevation MI (STEMI) has soared, according to a paper published in the Lancet. Although the study finds that there have been some genuine improvements in treatment, the Chinese healthcare system still has a long way to go to improve […]
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension